scholarly article | Q13442814 |
P50 | author | Bernhard Dietzschold | Q118469424 |
P2093 | author name string | Morimoto K | |
Hooper DC | |||
Weihe E | |||
Kean RB | |||
Scott GS | |||
Mikheeva T | |||
Spitsin SV | |||
Bette M | |||
Röhrenbeck AM | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammation | Q101991 |
P304 | page(s) | 3470-3477 | |
P577 | publication date | 2001-09-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent | |
P478 | volume | 167 |
Q45095469 | Altered circadian relationship between serum nitric oxide, carbon dioxide, and uric acid in multiple sclerosis. |
Q39315583 | Animal models of CNS viral disease: examples from borna disease virus models |
Q44823899 | Attenuation of chronic neuroinflammation by a nitric oxide-releasing derivative of the antioxidant ferulic acid |
Q36926813 | Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity |
Q45387671 | Bovine herpesvirus 5 induces an overproduction of nitric oxide in the brain of rabbits that correlates with virus dissemination and precedes the development of neurological signs. |
Q28478219 | Breakdown of the blood-brain barrier during tick-borne encephalitis in mice is not dependent on CD8+ T-cells |
Q33992923 | Cannabinoids and Viral Infections. |
Q27481326 | Correlation between breakdown of the blood–brain barrier and disease outcome of viral encephalitis in mice |
Q30925958 | Differential expression of growth factors at the cellular level in virus-infected brain |
Q39969705 | Disruption of IFN-gamma- mediated antiviral activity in neurons: the role of cannabinoids |
Q36798405 | Early blood-brain barrier permeability in cerebella of PLSJL mice immunized with myelin basic protein. |
Q45423987 | Expression of allograft inflammatory factor-1 and haeme oxygenase-1 in brains of rats infected with the neurotropic Borna disease virus |
Q24676227 | Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier |
Q47142365 | Low serum uric acid levels in patients with acute central nervous system viral infections. |
Q34589374 | Murine hepatitis virus--a model for virus-induced CNS demyelination. |
Q37400186 | Nitric oxide in dengue and dengue haemorrhagic fever: necessity or nuisance? |
Q40574996 | Peroxynitrite mediates nitric oxide-induced blood-brain barrier damage. |
Q29615424 | Peroxynitrite: biochemistry, pathophysiology and development of therapeutics |
Q36667290 | Plasma urate and risk of Parkinson's disease |
Q42082427 | Reovirus infection of the CNS enhances iNOS expression in areas of virus-induced injury |
Q58762198 | Rheumatoid meningitis presenting with a stroke-like attack treated with recombinant tissue plasminogen activator: a case presentation |
Q22252832 | Role of Uric Acid in Multiple Sclerosis |
Q85723240 | Serum urate and the risk of Parkinson's disease: results from a meta-analysis |
Q40892804 | Serum uric acid levels in patients with infections of central nervous system |
Q33863306 | Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccine |
Q89899084 | The dual role of TLR7 in the pathogenesis of rabies virus in a mouse model |
Q40234578 | The role of the proteasome-ubiquitin pathway in regulation of the IFN-gamma mediated anti-VSV response in neurons. |
Q37410626 | The roles of chemokines in rabies virus infection: overexpression may not always be beneficial |
Q39737738 | Therapeutic immune clearance of rabies virus from the CNS |
Q24541522 | Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. |
Q28190660 | Type I glutaric aciduria, part 2: a model of acute striatal necrosis |
Q33927539 | Uric acid protects against secondary damage after spinal cord injury |
Search more.